Education
About Us
Working with TipRanks
Follow Us
Genetic Technologies Limited (GNTLF)
:GNTLF
Total Valuation
Genetic Technologies has a market cap or net worth of $3.68M. The enterprise value is $15.50M.
Market Cap$3.68M
Enterprise Value$15.50M
Share Statistics
Genetic Technologies has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Genetic Technologies’s return on equity (ROE) is -6.57 and return on invested capital (ROIC) is -429.43%.
Return on Equity (ROE)-6.57
Return on Assets (ROA)-1.94
Return on Invested Capital (ROIC)-429.43%
Return on Capital Employed (ROCE)-6.13
Revenue Per Employee139.36K
Profits Per Employee-218.49K
Employee Count55
Asset Turnover1.24
Inventory Turnover18.21
Valuation Ratios
The current PE Ratio of Genetic Technologies is -0.89. Genetic Technologies’s PEG ratio is -0.03.
PE Ratio-0.89
PS Ratio0.00
PB Ratio1.74
Price to Fair Value5.85
Price to FCF-1.99
Price to Operating Cash Flow-1.99
PEG Ratio-0.03
Income Statement
In the last 12 months, Genetic Technologies had revenue of 7.66M and earned -12.02M in profits. Earnings per share was -0.09.
Revenue7.66M
Gross Profit3.90M
Operating Income-12.21M
Pretax Income-12.02M
Net Income-12.02M
EBITDA-11.43M
Earnings Per Share (EPS)-0.09
Cash Flow
In the last 12 months, operating cash flow was -9.56M and capital expenditures -11.73K, giving a free cash flow of -9.57M billion.
Operating Cash Flow-9.56M
Free Cash Flow-9.57M
Free Cash Flow per Share―
Dividends & Yields
Genetic Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta31.59
52-Week Price Change108.33%
50-Day Moving Average0.93
200-Day Moving Average―
Relative Strength Index (RSI)67.59
Average Volume (3m)100.00
Important Dates
Genetic Technologies upcoming earnings date is Aug 28, 2025, TBA Not Confirmed.
Last Earnings DateFeb 26, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date―
Financial Position
Genetic Technologies as a current ratio of 0.88, with Debt / Equity ratio of 4.77%
Current Ratio0.88
Quick Ratio0.83
Debt to Market Cap0.06
Net Debt to EBITDA0.01
Interest Coverage Ratio-236.53
Taxes
In the past 12 months, Genetic Technologies has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Genetic Technologies EV to EBITDA ratio is -0.92, with an EV/FCF ratio of -1.09.
EV to Sales1.38
EV to EBITDA-0.92
EV to Free Cash Flow-1.09
EV to Operating Cash Flow-1.09
Balance Sheet
Genetic Technologies has $1.02M in cash and marketable securities with AU$875.19K in debt, giving a net cash position of -$145.42K billion.
Cash & Marketable Securities$1.02M
Total DebtAU$875.19K
Net Cash-$145.42K
Net Cash Per Share―
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 58.10%, with operating margin of -159.30%, and net profit margin of -156.78%.
Gross Margin58.10%
Operating Margin-159.30%
Pretax Margin-156.78%
Net Profit Margin-156.78%
EBITDA Margin-149.13%
EBIT Margin-156.11%
Analyst Forecast
The average price target for Genetic Technologies is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―